Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111269156B reveals a novel copper-catalyzed cross-coupling method for synthesizing 1,2,4-tricarbonyl sulfoxide ylides, offering mild conditions and high structural diversity for pharmaceutical applications.
Patent CN104529895B reveals a one-step aqueous synthesis for isoquinoline derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. Achieve cost reduction in pharmaceutical intermediate manufacturing with high purity and scalability.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN117362140B reveals high-yield photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113072478B details a mild copper-catalyzed N-arylation method using aryl silanes, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111662147A reveals a green copper-catalyzed method for diacetylenes, offering cost reduction and scalable manufacturing for pharmaceutical and material science applications.
Patent CN111848480A details a copper-catalyzed method for synthesizing aryl difluoromethylselenyl ethers from boronic acids, offering cost-effective routes for drug discovery.
Patent CN119462473B details a nickel-catalyzed route for pyrrolidine units, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. This method offers significant cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Innovative copper(I)-catalyzed method for 1,3-enyne synthesis eliminates expensive palladium, offering high purity and scalable production for pharmaceutical intermediates.
Novel indole-skeleton phosphine ligand enables high-yield C-S bond formation with reduced catalyst loading, offering significant supply chain reliability for pharmaceutical intermediates.
Breakthrough intramolecular cross-dehydrogenation coupling method enables efficient production of coumarin heteroaromatic compounds with significant cost reduction and enhanced supply chain reliability.
Patent CN106187656B enables >99% selective monoarylation under mild conditions, reducing costs and lead times for high-purity fine chemicals.
Discover how air-promoted nanopalladium Suzuki coupling in PEG eliminates inert gas needs, reduces costs, and achieves 99% yields for pharmaceutical intermediates.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. 0.5 mol% catalyst, 90% yield. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve allyl sulfone production challenges with catalyst-free, high-yield synthesis. Reduce costs, eliminate heavy metals, and ensure supply chain stability for drug development.
Solve supply chain risks with mild, high-yield synthesis of benzodihydrofuran intermediates. 80%+ yields, functional group tolerance, and scalable production for pharma R&D and procurement.